The ghost of clinical trials past, present, and future; Have you seen many paradigm shifts lately?

By David Connelly

“What is more tiring for anyone in this industry to hear? Is it the most oft-quoted statistic from the Tufts Center for the Study of Drug Development that the average cost of getting a drug developed through to marketing approval is $2.87 billion; or the blaming of the FDA?”…

[Click HERE to read the full article]